Shares of BTG plc (LON:BTG – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 840 ($10.55) and traded as high as GBX 840 ($10.55). BTG shares last traded at GBX 840 ($10.55), with a volume of 271,742 shares trading hands.
BTG Stock Performance
The company has a market cap of £3.26 billion and a price-to-earnings ratio of 29.47. The firm’s 50 day simple moving average is GBX 840 and its 200-day simple moving average is GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Read More
- Five stocks we like better than BTG
- Earnings Per Share Calculator: How to Calculate EPS
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Monster Growth Stocks to Buy Now
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
